Zentalis Pharmaceuticals, Inc.

NasdaqGM:ZNTL Stock Report

Market Cap: US$892.0m

Zentalis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:ZNTL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Feb 24SellUS$18,291Mark LacknerIndividual1,585US$11.54
02 Feb 24SellUS$38,197Andrea PaulIndividual3,310US$11.54
13 Nov 23BuyUS$51,448Kimberly BlackwellIndividual5,000US$10.29
10 Nov 23BuyUS$167,943David JohnsonIndividual17,000US$9.88
20 Jun 23BuyUS$107,861,600Matrix Capital Management Company, LPCompany4,760,000US$22.66

Insider Trading Volume

Insider Buying: ZNTL insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ZNTL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,6150.00427%
Individual Insiders2,962,6663.5%
Hedge Funds17,641,75520.8%
Institutions64,016,36075.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.4%.


Top Shareholders

Top 25 shareholders own 109.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.7%
Matrix Capital Management Company, LP
13,959,973US$175.5m0%1.66%
16.3%
Eventide Asset Management, LLC
11,559,975US$145.3m47.9%2.61%
14.6%
FMR LLC
10,336,971US$129.9m8.88%0.01%
7.54%
The Vanguard Group, Inc.
5,350,458US$67.3m2.17%no data
7.39%
T. Rowe Price Group, Inc.
5,245,848US$65.9m11.9%0.01%
6.6%
BlackRock, Inc.
4,684,975US$58.9m6.58%no data
6.22%
State Street Global Advisors, Inc.
4,417,056US$55.5m63.4%no data
5.19%
Citadel Advisors LLC
3,681,782US$46.3m70.8%0.05%
3.97%
Capital Research and Management Company
2,819,664US$35.4m-26%no data
3.04%
Federated Hermes, Inc.
2,160,565US$27.2m10.9%0.08%
2.96%
Decheng Capital LLC
2,099,583US$26.4m0%3.06%
2.12%
Anthony Sun
1,504,144US$18.9m0%no data
1.98%
Woodline Partners LP
1,403,553US$17.6m40.4%0.2%
1.77%
Geode Capital Management, LLC
1,253,737US$15.8m5.64%no data
1.44%
PRIMECAP Management Company
1,023,350US$12.9m-1.01%0.01%
1.35%
Tybourne Capital Management (HK) Ltd.
961,486US$12.1m0%1.9%
1.02%
Dimensional Fund Advisors LP
724,033US$9.1m49.5%no data
1%
Bank of America Corporation, Asset Management Arm
708,643US$8.9m211%no data
0.99%
Kevin Bunker
699,358US$8.8m-1.9%no data
0.84%
Morgan Stanley, Investment Banking and Brokerage Investments
597,129US$7.5m12.4%no data
0.75%
Northern Trust Global Investments
530,003US$6.7m-1.98%no data
0.69%
5AM Venture Management, LLC
490,000US$6.2m0%1.23%
0.63%
Tavistock Life Sciences
450,000US$5.7m0%0.36%
0.63%
Charles Schwab Investment Management, Inc.
445,823US$5.6m0%no data
0.56%
Paradigm Biocapital Advisors LP
400,000US$5.0m0%0.27%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.